Table 3.
Toxicity | Grade 1 | Grade 2 | Grade 3 |
---|---|---|---|
Local skin reaction | 2 | 111 | 0 |
Rash (not at vaccine site) | 1 | 3 | 0 |
Arthralgias | 2 | 3 | 0 |
Constipation | 3 | 0 | 0 |
Cough | 4 | 0 | 0 |
Diarrhea | 1 | 0 | 0 |
Fatigue | 21 | 9 | 0 |
Fever | 14 | 10 | 0 |
Headache | 21 | 5 | 0 |
Myalgias | 38 | 6 | 0 |
Nausea | 5 | 0 | 0 |
Vomiting | 1 | 1 | 0 |
Rigors/chills | 13 | 0 | 0 |
Pruritis | 13 | 1 | 0 |
Increase in amylase | 2 | 0 | 1 |
Leukopenia | 7 | 2* | 0 |
Neutropenia | 3 | 1† | 0 |
Lymphopenia | 4 | 13‡ | 9§ |
Anemia | 5 | 0 | 1¶ |
Thrombocytopenia | 5 | 0 | 0 |
Total number of vaccinations: 134.
Both patients had pretreatment grade 1 values.
This patient had a pretreatment grade 1 value.
Twelve patients had pretreatment grade 2 values.
Six patients had pretreatment grade 3 values; 3 patients had pretreatment grade 2 values.
This patient had a pretreatment grade 3 value.